Changes of plasma endothelin and atrial natriuretic peptide concentrations in children with heart failure and therapeutic effect of milrinone
RUAN Jing, CAI Chang-Hui, ZHENG Kai-Jun, DENG Xiang-Hong
Abstract No abstract available
Cite this article:
RUAN Jing,CAI Chang-Hui,ZHENG Kai-Jun et al. Changes of plasma endothelin and atrial natriuretic peptide concentrations in children with heart failure and therapeutic effect of milrinone[J]. 中国当代儿科杂志, 2001, 3(4): 411-412.
RUAN Jing,CAI Chang-Hui,ZHENG Kai-Jun et al. Changes of plasma endothelin and atrial natriuretic peptide concentrations in children with heart failure and therapeutic effect of milrinone[J]. CJCP, 2001, 3(4): 411-412.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2001/V3/I4/411
[1]
CHENG Yao-Yao, AN Jin-Dou, FENG Song, GE Wei. Changes in serum chromogranin A and urotensin II levels in children with chronic heart failure
[2]
LI Bing-Lu, AN Jin-Dou, FENG Song, GE Wei. Change in serum follistatin-like protein 1 and its clinical significance in children with chronic heart failure
[3]
LI Wei, DU Jun-Bao, JIN Hong-Fang. Effects of hydrogen sulfide donor on production of adrenomedullin and atrial natriuretic peptide in rats with atherosclerosis
[4]
LIN Chun-Wang, ZENG Xiang-Lin, MENG Xiu-Hui, JIANG Shao-Hu, OU-YANG Hui. Clinical importance of preoperative measurement of plasma amino-terminal pro-B-type natriuretic peptide in infants with congenital heart disease
[5]
YAO Ai-Min, HAO Ya-Ping, ZHANG Jie, SUN Xue-Jiang, WANG Hong-Ying, LI Bin, LI Jian-Ling. Changes in plasma levels of atrial natriuretic peptide, endothelin-1 and von Willebrand factor among newborns with persistent pulmonary hypertension
[6]
PENG Jing, FU Jia, DENG Shu-Zhen, WANG Rui-Geng, LIU Ling, SUN Dong-Ming, XIA Kun. Changes in serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3, and their significance in children with left-to-right shunt congenital heart disease associated with heart failure
[7]
LI Yan, WANG Xian-Min, LIU Yi-Ling, SHI Kun, YANG Yan-Feng, GUO Yong-Hong. Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure
[8]
SUN Yu-Ping, WANG Wen-Di, MA Shao-Chun, WANG Li-Yan, QIAO Ling-Yan, ZHANG Li-Ping. Changes of heart--type fatty acid-binding protein in children with chronic heart failure and its significance
[9]
WANG Jian-Rong, ZHOU Ying, SANG Kui, LI Ming-Xia. Association between pulmonary vascular remodeling and expression of hypoxia-inducible factor-1α, endothelin-1 and inducible nitric oxide synthase in pulmonary vessels in neonatal rats with hypoxic pulmonary hypertension
[10]
ZHANG He, LI Jiu-Jun. Correlation between the blood serum BNP level and the left cardiac function in children with congenital heart disease
[11]
ZHOU Ying, WANG Le, LI Ming-Xia. Serum levels of HIF-1α, ET-1 and Ca2+ in neonates with hypoxic pulmonary hypertension
[12]
WANG Li, ZHU Yan-Ping, LI Ming-Xia. Role of hypoxia-inducible factor-1α endothelin-1 and inducible nitric oxide synthase in the pathogenesis of hypoxia-induced pulmonary hypertension of the newborn
[13]
LI Jiu-Jun, LIU Chun-Feng, YUAN Zhuang, DAI Bing. Treatment of congenital heart disease complicated by severe bronchopneumonia in infants
[14]
HUANG Li-Xin, WU Xing-Heng. Effect of Xinmailong on hypoxia-inducible factor-1α expression in neonatal rats with asphyxia
[15]
ZHANG Shen-Rong, ZHANG Yuan-Hai, XU Qiang, QIU Hui-Xian, CHEN Qi. Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease
